Newstral
Teva
- MTiny armored animals — known for ‘screaming’ — born at New Orleans zoo. See themmiamiherald.com
- Thousands of free opioid overdose reversal kits headed to Washington - Thu, 16 May 2024 PSTThe Spokesman-Review
- The 7 Best Hiking Sandals, According To Gear ExpertsForbes
- Cute chicks hatch at California zoo. One carries on legacy of sandal-wearing penguinsacbee.com
- SHoka to open stores in Causeway Bay, Mong Kok as running shoe brand eyes rapid growth of fitness, health market in Asiascmp.com
- US FTC Continues Aggressive Scrutiny of Pharmaceutical Patents Listed in the Orange Bookjdsupra.com
- Federal Circuit Review - April 2024jdsupra.com
- European Commission’s First-Ever Abuse of Dominance Probe for Shelving of a Novel Pipeline Therapyjdsupra.com
- Alvotech and Teva’s Selarsdi™ (ustekinumab-aekn), Biosimilar to Stelara® Approved by FDAjdsupra.com
- FDA Approval of Alvotech/Teva Ustekinumab Biosimilarjdsupra.com
- Obviousness Analysis Does Not Consider Unclaimed Limitationsjdsupra.com
- Genentech and Dr. Reddy’s Settle BPCIA Litigation Against Proposed Rituxan Biosimilar DRL_RIjdsupra.com
- Patent Case Summaries | Week Ending April 5, 2024jdsupra.com
- Janssen v. Teva: Not an April Fool’s Day Joke for Life Sciences Companiesjdsupra.com
- Vanda Swings for the Fences and Asks the Supreme Court to Heighten the Standard for Obviousnessjdsupra.com
- Bill would increase penalty on EpiPen manufacturers for flouting Colorado’s price capDenver Post
- European Commission opens unprecedented abuse of dominance probe in animal medicines sectorjdsupra.com
- Avatar’s Paul Sun-Hyung Lee wants to geek out with the fans of the futureThe Verge
- Carrots and Sticks: DOJ’s Push to Incentivize Voluntary Disclosure of Corporate Misconduct (Part II of II)jdsupra.com
- TBiden, Sanders to take victory lap after drugmakers cap cost of inhalersthehill.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.